Loratadine: A non-sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood and sedation

Clinical and Experimental Allergy, Supplement

Volumn 29, Issue 3, 1999, Pages 147-150

  Kay, G G ^a   Harris, A G ^b  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

CNS functioning; Cognition; Loratadine; Psychomotor function

Indexed keywords

ANTIHISTAMINIC AGENT; DIPHENHYDRAMINE; LORATADINE;

ADULT; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DROWSINESS; DRUG EFFECT; HUMAN; MOOD; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEDATION;

EID: 0032784403     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.0290s3147.x     Document Type: Review

References (19)

1. Kay GG, Plotkin KE, Quig MB, Starbuck VN, Yasuda S. Sedating effects of AM/PM antihistamine dosing with evening chlorpheniramine and morning terfenadine. Am J Man Care 1997;3:1843-8.
2. Reeves DL, Winter KP, LaCour S, et al. Automated Neuropsychological Assessment Metrics Documentation, Vol. I Test Administration Guide, Silver Springs, MD. Office of Military Performance Assessment Technology 1992.
3. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement W. Quantification of sleepiness. A new approach. Psychophysiol 1973; 10:431-6.
4. Kay GG, Berman B, Harris A. Self-reported sedation doesn't predict impaired CNS functioning after dose of sedating antihistamine. J Allergy Clin Immunol 1999; 103: Abstract 975, S254.
5. Matejcek M. Vigilance and the EEG. psychological, physiological and pharmacological aspects. In: Hermann WM, ed. EEG in Drug Research New York: Gustav Fischer, 1982: 405-508.
6. Ramaekers JG, Uiterwijk MMC, O'Hanlon JF. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur J Clin Pharmacol 1992; 42:363-9.
7. Nicholson AN, Stone BM. Antihistamines: Impaired performance and the tendency to sleep. Eur J Clin Pharm 1986; 30:27-32.
8. Kay GG, Berman B, Mockoviak SH, et al. Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood and psychomotor performance. Arch Int Med 1997; 157:2350-6.
9. de Roeck J, Cluydts R, Cosyns P. The sensitivity of methods used for the evaluation of drug induced daytime sedation. J Psychopharmacol 1992; :A6.
10. Roth T, Roehrs T, Koshorek G, Sicklesteel J, Zorick F. Sedative effects of anthihistamines. J Allergy Clin Immunol 1987; 80:94-.
11. 1-receptor antagonists. Clin Exp Allergy 1996; 26:1092-7.
12. Schweitzer PK, Muehlbach MJ, Walsh JK. Sleepiness and performance during three-day administration of cetirizine or diphenhydramine. J Allergy Clin Immunol 1994; 94:716-24.
13. Koelega HS. Stimulant drugs and vigilance performance: a review. Psychopharmacol 1993; 111:1-16.
14. Moskowitz H. Attention tasks as skills performance measures of drug effects. Br J Clin Pharmac 1984; 18 (Suppl.):51-61.
15. Rombaut NIE, Hindmarch I. Psychometric aspects of antihistamines: a review. Hum Psychopharmacol 1994; 9:157-69.
16. Kay GG, CogScreen (Aeromedical edn). Professional Manual. Odessa, FL: Psychological Assessment Resources, Inc. 1995.
17. Hoffmann CC, Hoffmann KP, Kay GG. The role that cognitive ability plays in CRM, human factors and medicine panel symposium on collaborative crew performance in complex operational systems. Edinburgh, UK: NATO Research & Technology Agency, 1998.
18. O'Hanlon JF. Antihistamines and driving safety. Cutis 1988; 42:10-3.
19. O'Hanlon JF, Ramaekers JG. Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience. Allergy 1995; 50:234-42.